Cadian Capital Management, LP Guardant Health, Inc. Transaction History
Cadian Capital Management, LP
- $2.8 Billion
- Q1 2024
A detailed history of Cadian Capital Management, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 5,792,779 shares of GH stock, worth $157 Million. This represents 4.28% of its overall portfolio holdings.
Number of Shares
5,792,779
Previous 710,000
715.88%
Holding current value
$157 Million
Previous $19.2 Million
522.26%
% of portfolio
4.28%
Previous 0.79%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
309Shares Held
110MCall Options Held
2.51MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA11.4MShares$310 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$298 Million0.01% of portfolio
-
Baillie Gifford & CO6.23MShares$169 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$163 Million4.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.18MShares$113 Million1.39% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.77B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...